Background/Aims: The purpose of this study was to investigate the implications of protein kinase C-epsilon (PKCε), Extracellular Signal-regulated Kinase 1/2 (ERK1/2) and mitochondrial permeability transition pore (mPTP) in myocardial protection induced by morphine postconditioning (MpostC). Methods: The isolated rat hearts were randomly assigned into one of eight groups. Hearts in time control (TC) group were constantly perfused for 105min. Hearts in ischemia-reperfusion (I/R) group were subjected to 45 min of ischemia followed by 1 h of reperfusion. MpostC was induced by 10 min of morphine administration at the onset of reperfusion. εV 1-2 (an inhibitor of PKCε) and PD (an inhibitor of ERK1/2) was administered with or without morphine during the first 10 min of reperfusion following the 45 min of ischemia. I/R injury was assessed by functional parameters, creatine kinase-MB (CK-MB) release and infarct size (IS/AAR). Additional hearts were excised at 20 min following reperfusion to detect the membrane-specific translocation of PKCε, ERK1/2 phosphorylation, mitochondrial permeability transition (MPT) and cytochrome C (Cyt-c) release. Results: MpostC markedly reduced infarct size (IS/AAR), CK-MB release, and improved cardiac function recovery. However, these protective effects were partly abolished in the presence of εV 1-2 or PD. Compared to TC group, the membrane translocation of PKCε, ERK1/2 phosphorylation, mPTP opening, and Cyt-c release were significantly increased in I/R hearts. MpostC further increased the membrane translocation of PKCε and ERK1/2 phosphorylation, and significantly inhibited mPTP opening
Introduction
We previously demonstrated that administration of morphine immediately at the onset of reperfusion, namely morphine postconditioning (MpostC), reduced the infarct size to an extent similar to morphine preconditioning (MPC) [1] , and our recent study further showed that the cardioprotection induced by MpostC is via inhibiting JNK/p38 MAPK and mitochondrial permeability transition pores (mPTP) signaling pathway [2] . Because anisomycin (an activator of JNK/p38 kinases) only partly reversed the infarct-sparing effect of MpostC, it implies that there might be alternative mechanisms involved in MpostC.
One family of signaling proteins commonly linked to the modulation of ischemia-reperfusion injury is protein kinase C (PKC), particularly the PKC isozyme PKCε [3, 4] . Previous research demonstrated that membrane translocation of PKCε was critical to triggering cardioprotective effects in both ischemic preconditioning (preC) [5] and ischemic postconditioning (postC) [6, 7] . Furthermore, PKCε activation is also involved in the cardioprotective effect produced by opioid receptor agonist induced preC [8, 9] . Is PKCε also involved in opioid receptor agonist induced posC? And if it is, what is the potential downstream target of PKCε activation? All these questions are still unclear.
Extracellular signal-regulated kinase (ERK) 1/2 is one important component of reperfusion injury survival kinases (RISK), which are activated at the time of reperfusion and afforded opportunity for protecting the heart against lethal reperfusion-induced injury [10] . Evidence shows that the activation of ERK1/2 was implicated in both preC [11] and postC [12] , indicating that preC and postC possibly recruit a common signal pathway during myocardial reperfusion. Furthermore, recent studies suggested that the phosphorylation of ERK1/2 was involved in opioid receptor agonist induced postC [13, 14] , but the exact mechanism through which ERK1/2 was activated in opioid-induced postC remains unclear.
It is well known that mPTP plays a paramount role in reperfusion injury [15] , and studies showed that both ischemic and anesthetic induced postC afford cardioprotection via inhibiting mPTP opening by activation of ERK1/2 [16, 17] . Therefore, the objective of the present study was to determine whether the RISK pathway (PKCε and ERK1/2) and mPTP were involved in MpostC-induced cardioprotection.
Materials and Methods
All experimental procedures and protocols used in this investigation were reviewed and approved by the Institutional Animal Care and Use Committee of the Affiliated Hospital of Qingdao University and were performed in accordance with the Guide for the Care and Use of Laboratory Animals from the Institute of Laboratory Animals Resources.
Isolated Heart Preparation
Preparation of isolated rat hearts was performed as we previously described [1] . In brief, male SpragueDawley rats weighing 180-200 g were anesthetized with an intraperitoneal injection of 40 mg/kg sodium pentobarbital and decapitated. The hearts were rapidly excised, mounted on a Langendorff apparatus, and retrogradely perfused at 100 cm H 2 O with Krebs-Ringer's solution (115 mM NaCl, 5 mM KCl, 1.2 mM MgSO4, 1.2 mM KH 2 PO 4 , 1.25 mM CaCl 2 , 25 mM NaHCO 3 , and 11 mM glucose) gassed with 95% O 2 -5% CO 2 (pH 7.4, temperature 37°C). A fluid-filled latex balloon was inserted through left atrium and passed through the mitral orifice into the left ventricle. The balloon was connected to a pressure transducer for continuous monitoring of left ventricular developed pressure (LVDP), left ventricular end-diastolic pressure (LVEDP) and heart rate (HR) via PowerLab Systems (PowerLab/8sp, AD Instruments, Australia). At first, the heart was ongoing a 15-min stabilization period, and any heart showing intractable arrhythmia or low left ventricular systolic pressure (LVSP) < 50 mmHg was excluded from the study.
Experimental Protocols
All hearts were randomly divided into 1 of 8 groups (n = 8, respectively)v (Fig. 1) . ①TC group (time control): hearts were constantly perfused with K-R buffer for 105 min; ②I/R group (ischemic control): hearts were subjected to 45 min of ischemia followed by 1 h of reperfusion; ③MpostC group (morphine, 3.0 μmol/L); ④MpostC +εV 1-2 group: εV 1-2 (PKCε inhibitor), 1.0 μmol/L]; ⑤εV 1-2 group; ⑥MpostC +PD group: PD (ERK1/2 inhibitor), 20.0 μmol/L; ⑦PD group; ⑧DMSO group (DMSO, 0.02%). After a 45-min ischemia period, hearts in group ⑤, ⑦ and ⑧ were administered morphine (3.0 μmol/L), εV 1-2 , PD and DMSO respectively for 10 min at the onset of reperfusion, and then were followed by 50 min reperfusion, while hearts in group ④ and ⑥ were treated with morphine (3.0 μmol/L) co-administered with εV 1-2 and PD for 10 min at the onset of reperfusion respectively, and then were followed by 50 min reperfusion. Additional hearts were used 20 min after reperfusion of the above 8 groups (n = 5, respectively) to detect the membranespecific translocation of PKCε (group①-⑤), ERK1/2 phosphorylation, mitochondrial permeability transition (MPT) and cytosolic levels of cytochrome C (Cyt-c) (group①-⑧). The concentrations used in this study were based on previous studies [1, 17, 18] , and all reagents, unless specified, were obtained from Sigma Chemicals (St. Louis, MO).
Determination of myocardial infarct size and myocardial injury
Myocardial infarct size and myocardial injury were measured as we previously described [1] . In short, infarct size was determined by 2, 3, 5-triphenyltetrazolium chloride (TTC) staining method, and infarct size was determined by dividing the total necrotic area of the left ventricle by the total left ventricular slice area (IS/AAR). In addition, the release of CK-MB, expressed as U/h/g, was measured by collecting total coronary effluent over the 60 min reperfusion period.
Cytosolic and particulate fraction preparation
Cytosolic protein contents and particulate fraction of the myocardium were prepared in accordance with Gao et al. [19] . In brief, frozen samples were homogenized at 0°C-4°C in buffer A consisting of 50 mM Tris-Cl, pH 7.5, 2 mM EDTA, 2 mM EGTA, 1mM dithiothreitol, and inhibitors for protease and phosphatase. These homogenates were centrifuged at 300,000 g for 30 minutes at 4°C in an Optima TLX Ultracentrifuge (Beckman Coulter CO.) to yield the cytosolic fraction. Resuspended in buffer B (buffer A + 0.5% Nonidet P-40), the crude membrane fraction pellet was sonicated and then centrifuged at 300,000 g for 30 minutes at 4°C. The final supernatant was the Heats in TC group were constantly perfused with K-R buffer for 105min. Hearts in other groups were subject to 45 min ischemia followed by 60 min reperfusion. MpostC was performed by a 10-min perfusion of morphine at the onset of reperfusion. εV 1-2 and PD was administered with or without morphine. Left ventricular tissue samples were collected for Western Blotting and spectrophotometric analysis at 20 min following reperfusion. Infarct size and CK-MB release were measured at the end of reperfusion. TC, time control; I/R, ischemia reperfusion; MpostC, morphine postcondtioning; PD, ERK1/2 inhibitor; DMSO, dimethyl sulphoxide. particulate fraction. The protein concentrations were measured by BCA protein assay kit (Pierce, Rockford, IL) and using bovine serum albumin standards.
Western blotting analysis 40μg of protein from each sample was loaded per lane in 10% SDS polyacrylamide gel electrophoresis (PAGE) gels. After being electrotransferred and blocked, the membrane was incubated overnight at 4°C with the primary antibody anti-PKCε (1:1000) and a secondary antibody conjugated with horseradish peroxidase (1:1000; Santa Cruz Biotechnology Inc., CA, USA) at room temperature. After washing three times, bands were detected using ECL-plus reagents (Pharmacia Biotech, Piscataway, NJ). To check the slight variation in protein loading between samples, western blot for β-actin was performed as an internal control. The relative optical density of bands from each sample was normalized against that of β-actin, and results were presented as a percentage of TC.
To determine the changes of ERK1/2 phosphorylation, 80μg of protein from the whole tissue homogenate was loaded per lane in 8% SDS-PAGE gel. The primary antibodies specific to ERK1/2 and phosphorylated ERK1/2
Thr-202/ Tyro-204 were purchased from Santa Cruz (1:1000; Santa Cruz Biotechnology Inc., CA, USA). The phosphorylation levels of ERK1/2 were expressed as a percentage of ERK1/2.
Detection of mPTP opening and Cyt -c release in cytosol
The preparation of mitochondria and cytosolic fractions and detection of mPTP opening and Cyt -c was performed as we previously described [2] . Left ventricular myocardium was homogenized in cold isolation medium, and cell debris was pelleted by centrifuging the homogenate twice for 5 min at 600 g; the supernatant was centrifuged for 10 min at 10 000 g at 4°C, then the pellet was resuspended in isolation buffer and washed twice by recentrifugation at 10 000 g for 10 min at 4°C; the final pellet was resuspended in isolation buffer as a mitochondrial preparation, and the supernatant was centrifuged for 1 h at 100,000 g to obtain cytosolic fraction. The protein concentrations were measured as above described.
Isolated mitochondria (1 mg protein) were resuspended in swelling buffer to a final volume of 2 ml, and incubated at 25°C for 2 min. mPTP opening, induced by 2, 20 and 200 μmol/L CaCl 2 , was followed by Mitochondrial permeability transition (MPT), and resulted in mitochondrial swelling, and was measured by spectrophotometry (DU800; Beckman Coulter, USA) as a reduction in the optical density at 540nm (OD540) during 5 min (ΔOD/min).
After SDS-PAGE, cytosolic proteins were transferred to a nitrocellulose membrane and incubated with anti-Cytochrome c and β-actin antibodies (mouse polyclonal antibodies diluted 1:200, Santa Cruz Biotechnology, USA) for 6 hours followed by a peroxidase-conjugated secondary antibody. The signal was detected and measured as ascribed above.
Statistical analysis
Data are expressed as mean ± SD. Hemodynamic data were analyzed using two-way repeated measures analysis of variance for time and treatment effects. If an overall significance was found, comparisons between groups were done for each time point using one-way analysis of variance, followed by Tukey post hoc testing. For other data, one-way analysis of variance with Tukey post hoc testing for multiple comparisons was used, and P < 0.05 (two-tailed) was considered statistically significant. ALL statistical analysis was performed with SPSS 19.0 software (SPSS Inc., Chicago, .USA).
Results

Effects on hemodynamics
The baseline hemodynamics were similar among all experimental groups (P > 0.05), and all variables remained constant in TC group during the experiment (Table 1) . Compared to baseline, the cardiac function in the other seven groups demonstrated deterioration at 10, 30, 60 min of reperfusion, as evidenced by an obvious reduction in CF, HR, and LVDP, and a significant increase in LVEDP (P < 0.05). All hemodynamic variables were better in MpostC group than those in I/R group (P < 0.05). However, the functional improvements elicited by MpostC were partly reversed by either εV 1-2 or PD, both of which did not influence 
Fig. 2. Effects of various treatments on infarct size (IS/AAR) (A) and CK-MB release (B). Infarct size was expressed as a percentage of the area at risk (IS/AAR).
TC group was not included because no obvious necrotic area was identified. TC, time control; I/R, ischemia reperfusion; MpostC, morphine (3.0 μmol/L); εV 1-2 , 1.0 μmol/L; PD, 20 μmol/L; DMSO, 0.02%. Values were presented as mean ± SD (n = 8/group). * P < 0.05 vs. TC, † P < 0.05 vs. I/R, § P < 0.05 vs. MpostC.
alone, showed no influence on the aspects (P = 0.12, P = 0.10; P = 0.10, P = 0.08). DMSO had no effect on IS/AAR and CK-MB release (P = 0.25, P = 0.20).
Effects on membrane-specific translocation of PKCε
Compared with TC group, the membrane translocation of PKCε from the cytosolic fraction to the particulate was significantly increased in I/R group (P < 0.05) (Fig. 3) . MpostC further enhanced the membrane translocation of PKCε, when compared to hearts in I/R group (P < 0.05). εV 1-2 , administered alone or together with morphine, significantly inhibited membrane translocation of PKCε (P < 0.05) (Fig. 3) , suggesting that PKCε activation is involved in MpostC. 
Effects on Ca
2+ induced mPTP opening When compared with TC group, ∆OD/min in the I/R group was markedly increased (P < 0.05), while hearts in MpostC group have a lower ∆OD/min than those of I/R group (Fig. 5) . When co-administered with morphine, either εV 1-2 or PD abolished the inhibitory effect on ∆OD/min observed with MpostC (P < 0.05). In addition, εV 1-2 , PD or DMSO had no influence on the ∆OD/min when used alone (P = 0.16, P = 0.25, P = 0.30).
Effects on cytosolic levels of Cyt-c
The cytosolic level of Cyt-c was significantly increased in I/R group, when compared to TC group (P < 0.05) (Fig. 6 ). Relative to I/R group, MpostC significantly reduced the level of Cyt-c in cytosol (P < 0.05). Both εV 1-2 and PD abolished the inhibitory effect of MpostC on Cyt-c release (P < 0.05), while εV 1-2 , PD or DMSO had no influence on cytosolic levels of Cyt-c (P = 0.11, P = 0.20, P = 0.33). 
Discussion
In the present study, we investigated the roles of PKCε, ERK1/2 and mPTP in morphineinduced postC in the isolated rat heart. The new findings were summarized as follows: (1) Because εV 1-2 and PD partly abolished the cardioprotection of MpostC, it indicated that both PKCε and ERK1/2 are involved in MpostC; (2) Subsequent western blot analysis showed that MpostC significantly enhanced PKCε membrane translocation and ERK1/2 phosphorylation. In addition, these effects were completely blocked by εV 1-2 , demonstrating that PKCε might be an upstream regulator of ERK1/2. (3) Because PD abolished the inhibitory effect on mPTP opening induced by MpostC, suggesting that such protective effect occurs downstream of ERK1/2 activation. Taken together, the present study showed that MpostC protects against reperfusion injury via activating PKCε-ERK1/2-mPTP signaling pathway in isolated rat heart.
The activation of PKC is associated with membrane translocation from the cytosol to the particulate fraction of the cell [20] , and the activation of PKC, in particular, the PKCε isoform, is pivotal in protecting hearts from ischemia reperfusion injury in preC [3] . Furthermore, studies suggested that the infarct-sparing effect of ischemic postC is also dependent on the activation of PKCε [6, 19] . Therefore, it seems that preC and postC might share some common pathways to protect the heart. Zhang and colleagues showed that remifentanil (an opioid analgesic) mimics cardioprotective effect of ischemic preC via PKC activation [21] , while the present study provided new evidence that the activation of PKC isoform ε is involved in cardiprotection induced by MpostC.
As an important reperfusion injury salvage kinase (RISK), ERK1/2 plays a pivotal role in protecting the heart against ischemia reperfusion injury [10, 22] , and studies indicated that the protective effects of ischemic and anesthetic postC were conferred by ERK1/2 phosphorylation [12, 17] . The present study demonstrated that MpostC protected the hearts against reperfusion injury through the phosphorylation of ERK1/2, which is consistent with what Ha et al. [13] and Kim et al. [14] suggested using remifentanil postC (an exogenous opioid receptor agonist) strategy. However, the mechanisms through which ERK1/2 is activated in postconditioned hearts are still unclear. The activation of ERK1/2 is regulated by phosphorylation, and this process was shown to be PKC-dependent [23] . Moreover, the PKCε-ERK1/2 signaling cascade was shown to be involved in the protective effect of ischemic preC [11, 24] , while the present study further verified that ERK1/2 phosphorylation is also regulated by PKCε translocation in MpostC, which offers new insights into the post-receptor signaling pathway in opioid receptor agonistinduced postC.
On the contrary, it was demonstrated that ERK1/2-dependent activation of PKCε was involved in desflurane preC induced protective effects in in vivo rat hearts [25] . Furthermore, Penna et al. suggested that acid postC protected against myocardial I/R injury by activating ERK1/2-PKCε pathways in isolated rat hearts [26] . Though the differences of treatments (preC versus postC), dugs (morphine versus desflurane or acid perfusion), and animal models (in vitro versus in vivo) might account for the inconsistent observations, we cannot exclude the presumption that there might be an ERK1/2-PKCε positive feedback regulation in postC, namely, that PKCε dependently phosphorylates ERK1/2 while the phosphorylated ERK1/2 in turn activates PKCε because it has been shown that ERK 1/2 is both upstream and downstream of PKC in preC [27] . More evidence is necessary to further verify this presumption.
It is well known that mPTP plays a paramount role in reperfusion injury [15, 28, 29] , and it has been strongly implicated as an end-effector in postC [27, 30] . We recently verified MpostC prevents mPTP opening via inhibiting JNK/p38 MAPK activation in isolated rat heats [2] . Given that anisomycin only partly reversed the infarct-sparing effect of MpostC, it implies that there might be alternative mechanisms involved in MpostC. Using the same experimental model, the present findings indicated that activating PKCε-ERK1/2 pathway is an alternative mechanism involved in inhibition of mPTP opening induced by MpostC, which is consistent with what Yao et al. founded using anesthetic-induced postC strategy [17] .
So far, the specific mechanism through which ERK1/2 regulates mPTP in myocardium is still unknown. It has been demonstrated that PKCε and ERK1/2 interact and form functional signaling modules in mitochondria [24] , furthermore, studies verified that the active PKCɛ, designated PKCɛ1 that is bound to the mitochondrial inner membrane, phosphorylates mK ATP and causes it to open [31] ; the resulting increase in K + influx with attendant matrix alkalinization then causes increased reactive oxygen species (ROS) production by complex I of the respiratory chain, and the ROS activates a second pool of PKCɛ, designated PKCɛ2, which inhibits MPT in a phosphorylation-dependent reaction [32] .
The current results must be interpreted within the following limitations.
(1) In contrast to an in vivo model, isolated hearts have a limited long-term biologic stability and may undergo short confounding ischemic periods during the surgical procedure, which could potentially affect our observation. (2) There is not general agreement concerning the optimal time of reperfusion necessary to assess myocardial infarct size on isolated perfused heart model. In isolated mice heart, Rossello et al. reported that infarct size progressively increases with the duration of both ischemia and reperfusion, and concluded that 180-min reperfusion might be optimal [33] . While in isolated rat heart, Ferrera and colleagues demonstrated that 60-min reperfusion is sufficient to demark infarct zones with no additional infarction occurring with longer periods of reperfusion [34] . In the present study with 45-min ischemia and 60-min reperfusion protocol in isolated rat heart, we cannot completely rule out the possibility that the shorter reperfusion time might be insufficient to wash out LDH and cofactors from necrotic cells to influence the effect of TTC staining when compared to 2-3 h. Taken together, it is necessary to be prudent to explain the present results.
In conclusion, the present study shows MpostC protects isolated rat hearts against ischemia-reperfusion injury via activating PKCε-ERK1/2 pathway and inhibiting mPTP opening, which provides new insights into the post-receptor signal pathways involved in opioid-induced postC in myocardium.
